Genetic Variants and Lung Cancer Risk
Author Information
Author(s): Gsur A, Zidek T, Schnattinger K, Feik E, Haidinger G, Hollaus P, Mohn-Staudner A, Armbruster C, Madersbacher S, Schatzl G, Trieb K, Vutuc C, Micksche M
Primary Institution: Institute of Cancer Research, University of Vienna, Austria
Hypothesis
Do polymorphisms in the microsomal epoxide hydrolase gene influence lung cancer risk?
Conclusion
The study suggests that certain genetic variants in the mEH gene may reduce the risk of lung cancer, particularly adenocarcinoma.
Supporting Evidence
- The study included 277 lung cancer patients and 496 controls.
- Statistically significant differences were found in the distribution of mEH polymorphisms between cases and controls.
- The His113/His113 genotype was significantly lower in lung cancer cases compared to controls.
- Adjusted odds ratios indicated a protective effect of the mEH exon 3 polymorphism against lung cancer.
- Findings suggest that reduced mEH activity may be protective against lung cancer, especially adenocarcinoma.
Takeaway
Some people have genes that help protect them from lung cancer, especially if they have a specific change in their mEH gene.
Methodology
A case-control study was conducted with 277 lung cancer patients and 496 controls, analyzing genetic polymorphisms using PCR methods.
Potential Biases
Potential misclassification bias due to genotyping errors was noted.
Limitations
The study was limited to Austrian Caucasians, which may affect the generalizability of the results.
Participant Demographics
Participants were Austrian Caucasians, including 277 lung cancer patients and 496 controls.
Statistical Information
P-Value
0.014
Confidence Interval
0.20–0.75
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website